Orviva

Learn · Variants · 8q24/MYC

rs6983267 8q24/MYC

Increased risk for colorectal cancer. 8q24 region near MYC oncogene.

Curated · human-reviewed Health risk · Risk / effect allele: G · dbSNP

What is rs6983267?

rs6983267 is a single-nucleotide polymorphism (SNP) in the 8q24/MYC gene (8q24 region near MYC). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as GG. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs6983267 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
GGslightly elevatedIncreased risk for colorectal cancer. 8q24 region near MYC oncogene.82%
GT / TGtypicalIntermediate colorectal cancer risk.78%
TTtypical / lowerLower colorectal cancer risk at this locus.82%

How common is the G allele of rs6983267?

Minor-allele frequency by population (gnomAD / 1000 Genomes):

European50.0%
East Asian33.0%
African48.0%
South Asian45.0%
Admixed American47.0%
Global45.0%

Which drugs have annotations for rs6983267?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
Platinum compoundsEfficacy3

Is rs6983267 on 23andMe and AncestryDNA chips?

Yes — it is genotyped directly on 23andMe V3, 23andMe V4, 23andMe V5, AncestryDNA V1, AncestryDNA V2. Orviva reads it from a raw-data export without imputation.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.